These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10102685)

  • 1. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.
    Flodström M; Tyrberg B; Eizirik DL; Sandler S
    Diabetes; 1999 Apr; 48(4):706-13. PubMed ID: 10102685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
    Andersson AK; Flodström M; Sandler S
    Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.
    Heitmeier MR; Scarim AL; Corbett JA
    J Biol Chem; 1997 May; 272(21):13697-704. PubMed ID: 9153221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-).
    Liu D; Pavlovic D; Chen MC; Flodström M; Sandler S; Eizirik DL
    Diabetes; 2000 Jul; 49(7):1116-22. PubMed ID: 10909967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced PGE(2) formation is reduced from iNOS deficient murine islets.
    Andersson AK; Thorvaldson L; Carlsson C; Sandler S
    Mol Cell Endocrinol; 2004 May; 220(1-2):21-9. PubMed ID: 15196696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
    Mabley JG; Southan GJ; Salzman AL; Szabó C
    Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression.
    Johannesen J; Pociot F; Karlsen AE; Mandrup-Poulsen T; Nerup J
    Eur Cytokine Netw; 2001; 12(3):501-9. PubMed ID: 11566631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
    Andersson AK; Sandler S
    J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
    Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
    Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
    Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
    Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines affect PDX-1 expression, insulin and proinsulin secretion from iNOS deficient murine islets.
    Andersson AK; Börjesson A; Sandgren J; Sandler S
    Mol Cell Endocrinol; 2005 Aug; 240(1-2):50-7. PubMed ID: 16023781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
    Corbett JA; McDaniel ML
    J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.